New Releases from NCBI BookshelfLebrikizumab for treating moderate to severe atopic dermatitis in people 12 years and over.Lebrikizumab for treating moderate to severe atopic dermatitis in people 12 years and over.

By admin / February 11, 2025

Post Content

New Releases from NCBI BookshelfImproving the experience of health services for trans and gender-diverse young people and their families: an exploratory qualitative study.Improving the experience of health services for trans and gender-diverse young people and their families: an exploratory qualitative study.

New Releases from NCBI BookshelfNivolumab for adjuvant treatment of completely resected melanoma at high risk of recurrence in people 12 years and over (terminated appraisal).Nivolumab for adjuvant treatment of completely resected melanoma at high risk of recurrence in people 12 years and over (terminated appraisal).

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

Registration No: 771800548 Contact Number : +91-8249516996

Publication
Skill Development
Blog Writing

Research
Awareness Camp
Digital Research

Ngo Darpan
Service
Donation

Term and Condition
Privacy Policy
Disclaimer

Scroll to Top

New Releases from NCBI BookshelfLebrikizumab for treating moderate to severe atopic dermatitis in people 12 years and over.Lebrikizumab for treating moderate to severe atopic dermatitis in people 12 years and over.

Leave a Comment Cancel Reply

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.